References
- Hogg RS, O’Shaughnessy MV, Gataric N, Yip B, Craib K, Schechter MT, et al. Decline in deaths from AIDS due to new antiretrovirals. Lancet 1997; 349: 1294.
- Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338: 853–60.
- Mocroft A, Vella S, Benfield TL, Chiesi A, Miller V, Gargalianos P, et al. Changing patterns of mortality across Europe in patients infected with HIV. Lancet 1998; 352: 1725–30.
- Carpenter CCJ, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, et al. Antiretroviral therapy for HIV infection in 1998. JAMA 1998; 280: 78–86.
- Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimetre or less. N Engl J Med 1997; 337: 725–33.
- Collier AC, Coombs RW, Schoenfeld DA, Bassett RL, Timpone J, Baruch A, et al. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine and zalcitabine. N Engl J Med 1996; 334: 1011–7.
- Gulick RM, Mellors JW, Havlir D, Eron JJ, Gonzalez C, McMahon D, et al. Treatment with indinavir, zidovudine and lamivudine in adults with human immunodificiency virus infection and prior antiretroviral therapy. N Engl J Med 1997; 337: 734–9.
- Cameron DW, Heath-Chiozzi M, Danner S, Cohen C, Krav- cik S, Maurath C, et al. Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. Lancet 1998; 351: 543–9.
- Kirk O, Katzenstein T, Gerstoft J, Mathiesen L, Nielsen H, Pedersen C, et al. Combination therapy containing ritonavir plus saquinavir has superior short term antiretroviral efficacy; a randomised trial. AIDS 1999; 13: F9–F16.
- Merry C, Barry MG, Mulcahy F, Halifax KL, Back DJ. Saquinavir pharmacokinetics alone and in combination with nelfinavir in HIV-infected patients. AIDS 1997; 11: F117–20.
- Jensen-Fangel S, Larsen L, Thomsen HF, Nielsen LP, Black FT, Obel N. Behandling af hiv og aids patienter med proteaseinhibitor og to nucleosidanaloger. Ugeskrift for Læger 1999; 161: 1751–4.
- Salgo MP, Beattie D, Bragman K, Donatacci L, Jones M, Montgomery L. Saquinavir vs zalcitabine vs combination as treatment for advanced HIV infection in patients discontinuing/unable to take zidovudine. XI international conference on AIDS, Vancouver, July 1996.
- Casado JL, Perez-Elías MJ, Antela A, Sabido R, Martí-Belda P, Dronda F, et al. Predictors of long-term response to protease inhibitor therapy in a cohort of HIV-infected patients. AIDS 1998; 12: F131–5.
- Fätkenheuer G, Theisen A, Rockstroh J, Grabow T, Wicke C, Becker K, et al. Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients. AIDS 1997; 11: F113–6.
- Monforte AD, Testa L, Adorni F, Chiesa E, Bini T, Moscatelli GC, et al. Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV-1 infection. AIDS 1998; 12: 1631–7.
- O’Brien WA, Hartigan PM, Martin D, Esinhart J, Hill A, Benoit S, et al. Changes in plasma HIV-1 rna and CD4 + lymphocyte counts and the risk of progression to AIDS. N Engl J Med 1996; 334: 426–31.
- Mitsuyasu RT, Skolnik PR, Cohen SR, Conway B, Gill MJ, Jensen PC, et al. Activity of the soft gelatin formulation of saquinavir in combination therapy in antiretroviral-naive patients. AIDS 1998; 12: F103–9.
- Kaufmann GR, Duncombe C, Cunningham P, Beveridge A, Carr A, Sayer D, et al. Treatment response and durability of a double protease inhibitor therapy with saquinavir and ritonavir in an observational cohort of HIV-1-infected individuals. AIDS 1998; 12: 1625–30.
- Kaufmann D, Pantaleo G, Sudre P, Telenti A, for the Swiss HIV Cohort Study. CD4-cell count in HIV-1 infected individuals remaining viraemic with highly active antiretroviral therapy (HAART). Lancet 351: 723–24, 1998.
- Ledergerber B, Egger M, Opravil M, Telenti A, Hirschel B, Battegay M, et al. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Lancet 1999; 353: 863–8.